Beano®
Beano®, licence 80075323: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Beano Alpha-Galactosidase Enzyme Tablets, Beano Enzyme Tablets, Beano® Tablets
- Licence holder
- Medtech Products, Inc.
- NPN or DIN-HM
- 80075323
- Status
- Active licence
- Licence date
- 27 January 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| alpha-D-Galactoside galactohydrolase Source : alpha-Galactosidase | 300.0 Unités d'alpha-galactosidase du FCC | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 300.0 Unités d'alpha-galactosidase du FCC | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : alpha-Galactosidase | 5.2 milligramme | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 5.2 milligramme | Not calculated |
Non-medicinal ingredients
Silicon dioxide colloïdal, Stéarate de magnésium, Gluconate de calcium, Microcrystalline cellulose, Fécule de pommes de terre, D-Mannitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 5.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80075323
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.